Short-term small-dose intravenous iron trial to detect functional iron deficiency in dialysis patients

American Journal of Nephrology

Volumn 21, Issue 2, 2001, Pages 91-97

  Lin, Ja Liang ^a   Chang, Ming Yang ^a   Tan, Dan Tzu ^a   Leu, Mei Ling ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Anemia; Erythropoietin; Ferritin; Iron deficiency; Transferrin saturation

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON; IRON SACCHARATE; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; DIALYSIS; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; IRON DEFICIENCY ANEMIA; KIDNEY DISEASE; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ANEMIA, IRON-DEFICIENCY; FEMALE; HUMANS; IRON; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 0035009551     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046230     Document Type: Article

References (30)

1. Sunder-Plassmann G, Hörl WH: Erythropoietin and iron. Clin Nephrol 1997;47:141-157.
2. Fishbane S, Maesaka JK: Iron management in end-stage renal disease. Am J Kidney Dis 1997; 29:319-333.
3. Sunder-Plassmann G, Spitzaucr S, Hörl WH: The dilemma of evaluating iron status in dialysis patients - limitation of available diagnostic procedures. Nephrol Dial Transplant 1997;12: 1575-1580.
4. Sunder-Plassmann G, Hörl WH: Laboratory diagnosis of anemia in dialysis patients: Use of common laboratory tests. Curr Opin Nephrol Hypertens 1997;6:566-569.
5. Lin JL, Lim PS, Leu ML: Relationship of body iron status and serum aluminum in chronic renal insufficiency patients not taking any aluminum-containing drugs. Am J Nephrol 1995; 15:118-122.
6. Fishbane S, Kowalski EA, Imbriano LJ, Macsaka JK: The evaluation of iron status in hemodialysis patients. J Am Soc Nephrol 1996;7: 2654-2657.
7. Kalantar-Zadeh K, Hoffken B, Wunsch H, Fink H, Kleiner M, Luft FC: Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era. Am J Kidney Dis 1995;26:292-299.
8. Macdougall IC: Monitoring of iron status and iron supplementation in patients treated with erythropoietin. Curr Opin Nephrol Hypertens 1994;3:620-625.
9. Tarng DC, Chen TW, Huang TP: Iron metabolism indices for early prediction of the response and resistance to erythropoietin therapy in maintenance hemodialysis patients. Am J Nephrol 1995;15:230-237.
10. Blumberg AB, Marti HR, Graber CG: Serum ferritin and bone marrow iron in patients undergoing continuous ambulatory peritoneal dialysis. JAMA 1983;250:3317-3319.
11. Eschbach JW, Kelly MR, Haley NR, Abels RI. Adamson JW: Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med 1989;321:158-163.
12. Fishbane S, Frei GL, Macsaka JK: Reduction in recombinant human erythropoietin dose by the use of chronic intravenous iron supplementation. Am J Kidney Dis 1995;26:41-46.
13. Macdougall IC, Cavill I, Hulme B, Bain B, McGregor E, McKay P, Sander E, Coles GA, Williams JD: Detection of functional iron deficiency during erythropoietin treatment: A new approach. BMJ 1992;304:225-226.
14. Cazzola M, Ascari E: Red cell ferritin as a diagnostic tool. BrJ Haematol 1986;62:209-213.
15. Hastka J, Lasserre JJ, Schwarzbcek A, Hehlmann R, Stauch M: Zinc protoporphyrin as an alternative to ferritin in the management of the iron substitution of rHuEPO treated dialysis patients. Kidney Hypertens Disord 1991;20: 697-700.
16. Béguin Y, Loo M, R'Zik S, Santois B, Léjeune F, Rorive G, Fillet G: Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen. Blood 1993;82:2010-2016.
17. Fishbane S, Galgano C, Langley RC Jr, Canfield W, Maesaka JK: Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney Int 1997;52: 217-222.
18. Fairbanks VF, Beutler E: Iron deficiency; in Beutler E, Lichtman MA, Coller BS, Kipps TJ (eds): Williams Hematology. New York, McGraw-Hill, 1995, pp 490-509.
19. Hörl WH, Cavill I, Macdougall IC. Schaefer RM, Sunder-Plassmann G: How to diagnose and correct iron deficiency during r-huEPO therapy - a consensus report. Nephrol Dial Transplant 1996;11:246-250.
20. Cavill I: Disorders of iron metabolism: Diagnostic methods. Clin Haematol 1982;11:259-273.
21. Rosenberg ME: Role of transferrin measurement in monitoring iron status during recombinant human erythropoietin therapy. Dial Transplant 1992;21:81-90.
22. Moreb J, Popovtzer MM, Friedländer MM, Konijn AM, Hershko C: Evaluation of iron status in patients on chronic hemodialysis: Relative usefulness of bone marrow hemosiderin, serum ferritin, transferrin saturaiton, mean corpuscular volume, and red cell protoporphyrin. Nephron 1983;35:196-200.
23. Braun J, Hammerschmidt M, Schrieber M, Heidler R, Hörl WH: Is zinc protoporphyrin an indicator of iron-deficient erythropoiesis in maintenance hemodialysis patients? Nephrol Dial Transplant 1996;11:292-297.
24. Patruta SI, Hörl WH: Iron and infection. Kidney Int 1999;55(suppl 69):125-130.
25. Sunder-Plassmann G, Pastula SI, Hörl WH: Pathobiology of the role of iron in infection. Am J Kidney Dis 1999;34(suppl 2):25-29.
26. Patruta SI, Edlinger R, Sunder-Plassmann G, Hörl WH: Neutrophil impairment associated with iron therapy in hemodialysis patients with functional deficiency. J Am Soc Nephrol 1998; 9:655-663.
27. Collins A, Ebben J, Ma J: Frequent i.v. iron dosing is associated with higher death (abstract). J Am Soc Nephrol 1996;8:190.
28. Hoen B, Paul-Dauphin A, Hestin D, Kessler M: A multiple center prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998;9:869-876.
29. Cieri E: Does iron cause bacterial infections in patients with end-stage renal disease? ANNA J 1999;26:591-596.
30. Gunnell J, Yeun JY, Depner TA, Kaysen GA: Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 1999;33:63-72.